SHANGHAI, Jan. 14, 2023 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized OTM platform, announced the appointment of Dr. Mingdong Zhang to the company’s Scientific Advisory Board (SAB). Dr. Zhang will provide guidance on Pulnovo Medical’s clinical development and registration strategyand supporting the company’s global development plan. Pulnovo Medical is a medical device company […]
Financial
HVR CARDIO CLOSES ON $11 Million SERIES B FINANCING WITH FINLAND’S INNOVESTOR LIFE SCIENCE FUND AND TESI
HVR Cardio Announces New Leadership Team With Hiring Of CTO Tim Girton, CEO Tom Fleming HELSINKI, Finland and MINNEAPOLIS, Jan. 12, 2023 /PRNewswire/ — HVR Cardio, a clinical stage medical technology company developing Structural Heart cardiovascular products for transcatheter mitral valve repair, announced today that it has closed on its 10.7 million Euro ($11.1M US) Series B Round of financing. […]
Amarin Comments on Sarissa’s Notice to Call a Special Meeting of Amarin Shareholders
Highlights Significant Board Refreshment, Operational and Financial Improvements and Engagement with Sarissa Capital Management DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 11, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) (“Amarin” or the “Company”) today confirmed receipt of a requisition by Sarissa Capital Management LP (“Sarissa”) to convene a General Meeting […]
CardioSolution Announces New Regional Chief Medical Officers
These appointments will assist in providing underserved patients with critical cardiovascular care across the nation. CINCINNATI–(BUSINESS WIRE)–CardioSolution, a leading comprehensive cardiovascular service line provider, recently announced two new appointments to its Regional Chief Medical Officers (RCMO) team of board-certified interventional cardiologists. As the newest members of the RCMO team, Alan Berger, […]
Ra Medical Systems Completes Merger with Catheter Precision
Medtech Veteran and Catheter Precision CEO and Founder David Jenkins to Serve as Executive Chairman Enters Agreements to Raise up to $9.3 Million in Equity MT. OLIVE, N.J. & CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the completion of its previously announced […]
GE HealthCare Announces Agreement to Acquire IMACTIS to Strengthen Capabilities in Interventional Guidance
Acquisition expected to provide significant future expansion opportunity for the IMACTIS CT-Navigation system through GE HealthCare’s large installed base and global scale IMACTIS CT-Navigation enables intuitive pre-planning, continuous control, and navigation throughout a range of minimally invasive percutaneous procedures This acquisition is the latest example demonstrating that GE HealthCare is executing […]
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology
Westport, CT, Jan. 10, 2023 (GLOBE NEWSWIRE) — Leading Midwest healthcare system reports significant cost savings and noise reduction following evaluation of the PURE EP™ System Medical center signs agreement to acquire the Company’s digital signal processing technology for arrhythmia care BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced […]
Amarin Provides Preliminary Fourth Quarter and Full Year 2022 Revenue and Cash Position and Priorities for 2023
— Company Delivers Fourth Consecutive Quarter of U.S. Revenue Stabilization, Positive Fourth Quarter Cash Flow and Continued Progress on European Reimbursements — — Amarin to Present at 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023 — DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) — Amarin […]
Solid Biosciences Outlines Strategy for Leadership in Precision Genetic Medicines with Focus on Neuromuscular and Cardiac Diseases
– Investigational New Drug (IND) application for SGT-003, next-generation gene therapy for Duchenne muscular dystrophy utilizing novel capsid AAV-SLB101, expected in 2H-2023 – – Candidate selection and transition manufacturing process to transient transfection for AVB-202 for Friedrich’s Ataxia and AVB 401 in dilated cardiomyopathy continue – – Kevin Tan named Chief Financial Officer, experience […]
Amarin Board of Directors Announces Appointment of Murray W. Stewart, DM FRCP
— Dr. Stewart Brings More Than 30 Years of Cardiometabolic Academic and Industry Experience to Amarin’s Board –- –– Ongoing Board Refreshment Program Has Led to Approximately 70% New Independent Directors Named to the Board Over the Last 12 Months — DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 10, 2023 (GLOBE […]



